Knowledge translation research offers new perspective on treating stimulant use disorder
How diverse patient perspectives can be used to inform future clinical research and practice
Read MoreJune 15, 2021
How diverse patient perspectives can be used to inform future clinical research and practice
Read More
Drs. Eugenia Oviedo-Joekes and Anne Gadermann are among the 156 new and renewed Canada Research Chairs
Read More
As we enter into another exciting year of improving health outcomes for B.C. and beyond, we’re reflecting on some of the CHÉOS research from the past year
Read More
COVID-19 is one of the two public health emergencies currently facing British Columbia, writes Dr. Eugenia Oviedo-Joekes
Read More
Patient Voices is dedicated to amplifying the voices of research participants. Spike is a participant in the Opiate Assisted Therapy program provided by Providence Health Care’s Crosstown Clinic.
Read More
CHÉOS Trainee Kirsten Marchand recently explored the experiences of clients receiving injectable opioid agonist treatment.
Read More
As we enter into another exciting year of improving health outcomes for BC and beyond, we're reflecting on some of the CHÉOS research from the past year.
Read More
CHÉOS Scientist Dr. Eugenia Oviedo-Joekes is a co-author on the first-ever clinical guidelines for use of injectable opioid agonist treatment for opioid use disorder.
Read More
Read about the Scientists and research that appeared in the media this summer.
Read More
Dr. Eugenia Oviedo-Joekes is mentoring a team exploring dexamphetamine for treatment of patients receiving iOAT.
Read More